FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/11/038020 [Registered on: 12/11/2021] Trial Registered Prospectively
Last Modified On: 10/11/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   COMPARISON OF EPIDURAL(OUTSIDE SPINAL CORD)DEXAMETHASONE (STEROID)AND EPIDURAL MORPHINE(OPIOID)FOR POST OPERATIVE PAIN RELIEF IN TOTAL ABDOMINAL HYSTERECTOMY(REMOVAL OF UTERUS) 
Scientific Title of Study   COMPARISON OF EPIDURAL DEXAMETHASONE AND EPIDURAL MORPHINE FOR POST OPERATIVE ANALGESIA IN TOTAL ABDOMINAL HYSTERECTOMY  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  PRIYANKA CHANDRAN 
Designation  POST GRADUATE STUDENT 
Affiliation  VINAYAKA MISSIONS KIRUPANANDA VARIYAR MEDICAL COLLEGE AND HOSPITALS 
Address  ROOM NO:8,FIRST FLOOR,VINAYAKA MISSIONS KIRUPANANDA VARIYAR MEDICAL COLLEGE AND HOSPITALS,SALEM
ROOM NO:8,FIRST FLOOR,VINAYAKA MISSIONS KIRUPANANDA VARIYAR MEDICAL COLLEGE AND HOSPITALS,SEERAGAPADI SANKARI MAIN ROAD NH47 SALEM 636308 TAMILNADU
Salem
TAMIL NADU
636308
India 
Phone  9789092597  
Fax    
Email  CPRIYANKA55@GMAIL.COM  
 
Details of Contact Person
Scientific Query
 
Name  VIGNESHWARAN S 
Designation  ASSISTANT PROFFESSOR 
Affiliation  VINAYAKA MISSIONS KIRUPANANDA VARIYAR MEDICAL COLLEGE AND HOSPITALS 
Address  ROOM NO:8,FIRST FLOOR,VINAYAKA MISSIONS KIRUPANANDA VARIYAR MEDICAL COLLEGE AND HOSPITALS,SALEM
ROOM NO:8,FIRST FLOOR,VINAYAKA MISSIONS KIRUPANANDA VARIYAR MEDICAL COLLEGE AND HOSPITALS,SEERAGAPADI SANKARI MAIN ROAD NH47 SALEM 636308 TAMILNADU
Salem
TAMIL NADU
636308
India 
Phone  9789092597  
Fax    
Email  DRVIGNESHWARANS@GMAIL.COM  
 
Details of Contact Person
Public Query
 
Name  PRIYANKA CHANDRAN 
Designation  POST GRADUATE STUDENT 
Affiliation  VINAYAKA MISSIONS KIRUPANANDA VARIYAR MEDICAL COLLEGE AND HOSPITALS 
Address  ROOM NO:8,FIRST FLOOR,VINAYAKA MISSIONS KIRUPANANDA VARIYAR MEDICAL COLLEGE AND HOSPITALS,SALEM
ROOM NO:8,FIRST FLOOR,VINAYAKA MISSIONS KIRUPANANDA VARIYAR MEDICAL COLLEGE AND HOSPITALS,SEERAGAPADI SANKARI MAIN ROAD NH47 SALEM 636308 TAMILNADU
Salem
TAMIL NADU
636308
India 
Phone  9789092597  
Fax    
Email  CPRIYANKA55@GMAIL.COM  
 
Source of Monetary or Material Support  
VINAYAKA MISSIONS KIRUPANANDA VARIYAR MEDICAL COLLEGE AND HOSPITALS 
 
Primary Sponsor  
Name  VINAYAKA MISSIONS KIRUPANANDA VARIYAR MEDICAL COLLEGE AND HOSPITALS 
Address  SEERAGAPADI,SALEM  
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
VIGNESHWARAN  ASSISTANT PROFESSOR, DEPARTMENT OF ANESTHESIA VINAYAKA MISSIONS KIRUPANANDA VARIYAR MEDICAL COLLEGE AND HOSPITALS  
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
PRIYANKA CHANDRAN  VINAYAKA MISSIONS KIRUPANANDA VARIYAR MEDICAL COLLEGE AND HOSPITALS  ROOM NO:8,FIRST FLOOR,OT COMPLEX,DEPARTMENT OF ANESTHESIA, VINAYAKA MISSIONS KIRUPANANDA VARIYAR MEDICAL COLLEGE AND HOSPITALS SEERAGAPADI
Salem
TAMIL NADU 
9789092597

CPRIYANKA55@GMAIL.COM 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Vinayaka Missions Kirupananda Variyar medical college & hospitals  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  EPIDURAL DEXAMETHASONE  8MG DEXAMETHASONE (2 ML) AS AN ADDITIVE TO 8ML 0.5% BUPIVACAINE EPIDURALLY IN ONE GROUP (ONE YEAR STUDY) 
Comparator Agent  EPIDURAL MORPHINE  4 MG MORPHINE IN 2 ML NORMAL SALINE AS AN ADDITIVE TO 8ML 0.5% BUPIVACAINE EPIDURALLY IN THE OTHER GROUP(ONE YEAR STUDY) 
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  60.00 Year(s)
Gender  Female 
Details  ASA 1 AND 2 PATIENTS UNDERGOING TOTAL ABDOMINAL HYSTERECTOMY UNDER EPIDURAL ANESTHESIA 
 
ExclusionCriteria 
Details  PATIENTS WHO ARE NOT WILLING FOR TRIAL, ALLERGIC TO DRUGS USED IN THE TRIAL, ASA GRADE 3 & 4, PATIENTS WHO ARE CONTRAINDICATED FOR EPIDURAL ANESTHESIA, PATIENTS REQUIRING GENERAL ANESTHESIA  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
TO DETERMINE THE POSTOPERATIVE ANALGESIC EFFICACY OF EPIDURAL DEXAMETHASONE AND EPIDURAL MORHINE AS ADDITIVES TO BUPIVACAINE USING VISUAL ANALOG SCALE  POST OPERATIVE ANALGESIA WILL BE ASSESSED UPTO 24 HOURS  
 
Secondary Outcome  
Outcome  TimePoints 
TO ASSESS THE ADVERSE EFFECTS OF EPIDURAL DEXAMETHASONE AND MORPHINE  ADVERSE EFFECTS WILL BE MONITORED FOR 24 HOURS 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   21/11/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   no publications yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   60 patients undergoing total abdominal hysterectomy under epidural anaeshesia will be recruited for the study. They will be randomized into two groups. One group will receive 4 mg morphine in 2 ml normal saline as an additive to    8 ml 0.5 % bupivacaine and the other group will receive 8 mg dexamethasone as an additive to 8 ml 0.5 % bupivacaine. The duration of postoperative analgesia will be assessed using visual analogue scale and the time of administration of first rescue analgesic will be noted and compared in both groups. Adverse effects will also be monitored.   
Close